Meeting program

October 11, 2019

09:00 - 09:10 Opening

09:10 - 10:40 Session 1: Acute Myeloid Leukemia (Diagnosis)

Chairs: K Döhner (Germany), A Bogdanovic (Serbia), R Niculescu (Romania)

Lecture: Diagnostic work-up of AML: State of the art
Speaker: K Döhner (Germany)

Clinical cases

  • Rare AML variants, diagnostic and management challenges
    C Matsouka (Greece)
  • AML FLT3-ITD case with FLU/MEL conditioning and PTCy
    Z Varady (Romania)
  • Concomitant presentation of t-AML and late relapse of multiple myeloma after autologous haematopoietic stem cell transplantation
    V Yankova (Bulgaria)

10:40 - 11:00 Coffee break

11:00 - 12:30 Session 2: Acute Myeloid Leukemia (Treatment)

Chairs: GJ Ossenkoppele (The Netherlands), A Ivanaj (Albania), M Pagoni (Greece)

Lecture: Treatment of AML: State of the art
Speaker: GJ Ossenkoppele (The Netherlands)

Clinical cases

  • Treatment of relapsed and refractory elderly AML patients
    İ Alacacıoğlu (Turkey)
  • FLT3 positive AML patient: treatment paradigms with FLT3 inhibitors
    I Mandac (Croatia)
  • AML Clinical Case
    O Karanfilksi (Macedonia)

12:30 – 13:30 Lunch

13:30 - 14:00 Keynote Lecture on CAR T Cells

Chairs: R Pieters (the Netherlands), D Konstantinov (Bulgaria), I Mandac (Croatia)

Lecture: The role of CART19-cells in the treatment of ALL
Speaker: J Delgado (Spain)

14:00 - 15:00 Session 3: Acute Lymphoblastic Leukemia (Pediatric)

Chairs: R Pieters (The Netherlands), D Konstantinov (Bulgaria), I Mandac (Croatia)

Lecture: Treatment of acute lymphoblastic leukemia guided by genetics and minimal residual disease
Speaker: R Pieters (The Netherlands)

Clinical case

  • ALL in a child
    N Yurukova (Bulgaria)

15:00 – 15:30 Coffee Break

15:30 – 17:00 Session 4: Acute Lymphoblastic Leukemia (Adult)

Chairs: R Bassan (Italy), H Özsan (Turkey), A Ukimeraj (Kosovo)

Lecture: Progress and challenges in adult ALL
Speaker: R Bassan (Italy)

Clinical cases

  • TKI in pregnancy
    A Cili (Albania)
  • Adult ALL
    S Dimitrova (Bulgaria)
  • BCR-ABL1(+) ALL – blast transformation or de novo acute leukemia in a JAK2 V617F(+) MPN patient
    Y Davidkova (Bulgaria)

17:00 – 17:10 Closing Remarks

17:10 – 17:20 Coffee break